The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Oral Androstenedione Administration and Serum Testosterone Concentrations in Young Men
Abstract
CONTEXT: Androstenedione, a steroid hormone and the major precursor to testosterone, is available without prescription and is purported to increase strength and athletic performance. The hormonal effects of androstenedione, however, are unknown. OBJECTIVE: To determine if oral administration of androstenedione increases serum testosterone levels in healthy men. DESIGN: Open-label randomized controlled trial conducted between October 1998 and April 1999. SETTING: General clinical research center of a tertiary-care, university-affiliated hospital. PARTICIPANTS: Forty-two healthy men aged 20 to 40 years. INTERVENTION: Subjects were randomized to receive oral androstenedione (either 100 mg/d [n = 15] or 300 mg/d [n = 14]) or no androstenedione (n = 13) for 7 days. MAIN OUTCOME MEASURES: Changes in serum testosterone, androstenedione, estrone, and estradiol levels, measured by frequent blood sampling, compared among the 3 treatment groups. RESULTS: Mean (SE) changes in the area under the curve (AUC) for serum testosterone concentrations were -2% (7%), -4% (4%), and 34% (14%) in the groups receiving 0, 100, and 300 mg/d of androstenedione, respectively. When compared with the control group, the change in testosterone AUC was significant for the 300-mg/d group (P<.001) but not for the 100-mg/d group (P = .48). Baseline testosterone levels, drawn 24 hours after androstenedione administration, did not change. Mean (SE) changes in the AUC for serum estradiol concentrations were 4% (6%), 42% (12%), and 128% (24%) in the groups receiving 0, 100, and 300 mg/d of androstenedione, respectively. When compared with the control group, the change in the estradiol AUC was significant for both the 300-mg/d (P<.001) and 100-mg/d (P = .002) groups. There was marked variability in individual responses for all measured sex steroids. CONCLUSIONS: Our data suggest that oral androstenedione, when given in dosages of 300 mg/d, increases serum testosterone and estradiol concentrations in some healthy men.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have shown that oral androstenedione and androstenediol supplementation increases serum levels of androstenedione and estradiol (E2) (36,37).”
From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [36]
Citations
Cites
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
Labrie, F., Luu-The, V., Lin, S.-X., Claude, L., Simard, J., Breton, R., & Bélanger, A. (1997) · Steroids · doi:10.1016/s0039-128x(96)00174-2 · Cited by 480
Conversion of blood androgens to estrogens in normal adult men and women
Longcope, C., Kato, T., & Horton, R. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106185 · Cited by 368
(1997) · PubMed · Cited by 363
Peliosis Hepatis Associated with Androgenic-Anabolic Steroid Therapy
Bagheri, S., & BOYER, J. L. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-5-610 · Cited by 257
Hepatotoxic Effects of the Anabolic/Androgenic Steroids
Ishak, K. G., & Zimmerman, H. J. (1987) · Seminars in Liver Disease · doi:10.1055/s-2008-1040579 · Cited by 200
Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids
Mcnutt, R., Ferenchick, G. S., Kirlin, P. C., & Hamlin, N. J. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91390-2 · Cited by 187
Weinstein, R. L., Kelch, R. P., Jenner, M. R., Kaplan, S. L., & Grumbach, M. M. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107526 · Cited by 170
BOURGUIGNON, J.-P. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-4-467 · Cited by 158
Forney, J. P., Milewich, L., CHEN, G. T., GARLOCK, J. L., Schwarz, B. E., Edman, C. D., & MacDonald, P. C. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-192 · Cited by 138
Cited by
Sorted by citations
Hormonal Responses and Adaptations to Resistance Exercise and Training
Kraemer, W. J., & Ratamess, N. A. (2005) · Sports Medicine · doi:10.2165/00007256-200535040-00004 · Cited by 1,389
Pursuit of the muscular ideal: physical and psychological consequences and putative risk factors
Cafri, G., Thompson, J. K., Ricciardelli, L., McCabe, M., Smolak, L., & Yesalis, C. (2005) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.09.003 · Cited by 504
Popular Ergogenic Drugs and Supplements in Young Athletes
Calfee, R., & Fadale, P. (2006) · Pediatrics · doi:10.1542/peds.2005-1429 · Cited by 280
Abuse of anabolic androgenic steroids and related substances in sport and exercise
Bahrke, M. S., & Yesalis, C. E. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.05.006 · Cited by 259
Androgen Abuse in Athletes: Detection and Consequences
Basaria, S. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1579 · Cited by 199
Metadata
- Authors
- Leder, B. Z.
- Affiliations
- Massachusetts General Hospital (US)
- Corresponding author
- Leder, Benjamin Z.
- ORCID
- Leder, Benjamin Z.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2000-02-09
- Volume
- 283
- Issue
- 6
- Pages
- 779
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2153302571
- Cited by
- 135
- References
- 21
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 6
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK02759, 5 R29 DK443341, K24DK002759)
- National Center for Research Resources (M01RR001066, RR-1066)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Social Sciences › Sociology and Political Science › Doping in Sports
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- androstenedione, testosterone, estradiol, estrone, young men, dose-response relationship, over-the-counter supplements, anabolic steroids, athletic performance improvement, over-the-counter drug regulation
- MeSH terms
- Administration, Oral, Adult, Androstenedione, Estradiol, Estrone, Humans, Male, Testosterone, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review